Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus

Hepato-Gastroenterology

Volumn 51, Issue 60, 2004, Pages 1575-1580

  Sakata, Haruhito ^a,e   Konishi, Masaru ^b   Ryu, Munemasa ^c   Kinoshita, Taira ^b   Satake, Mitsuo ^d   Moriyama, Noriyuki ^d   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c Chiba Prefectural Sawara Hospital   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e CHIBA UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Portal vein tumor thrombus; Radiological prognostic findings

Indexed keywords

AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CONTRAST MEDIUM;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANGIOGRAPHY; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LIVER CELL; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; TUMOR THROMBUS; VIRUS HEPATITIS;

ADULT; AGED; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM CIRCULATING CELLS; NEOPLASM INVASIVENESS; ONCOLOGY SERVICE, HOSPITAL; PORTAL VEIN; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 6344257073     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Okuda K, Kobert L, et al: Hepatocellular Carcinoma. New York: Wiley Medical Publication, 1976; pp. 196-197.
2. Stuart KE, Ajay JA, Roger LJ, et al: Hepatocellular carcinoma in the United States prognostic features, treatment outcome, and survival. Cancer 1996; 77:2217-2222.
3. Fong Y, Sun RL, William J, et al: An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 1999; 229:790-800.
4. Kaneko T, Nakao A, Inoue S, et al: Intracaval endovascular ultrasonography for intracaval tumor thrombus. J Am Coll Surg 1994; 179:604-606.
5. Fujii T, Takayasu K, Muramatsu Y, et al: Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis. Jpn J Clin Oncol 1993; 23:105-109.
6. Gianluigi G, Francesca P, Paolo T, et al: Occurrence of portai vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res 2002; 24:50-59.
7. Yamanaka N, Okamoto E, Toyosaka A, et al: Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 1990; 65:1104-1110.
8. Kumada K, Ozawa K, Okamoto R, et al: Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi. Surgery 1990; 108:821-827.
9. Katsumori T, Fujita M, Takahashi T, et al: Effective segmental chemoembolization of advanced hepatocellular carcinoma with tumor thrombus in the portal vein. Cardiovasc Intervent Radiol 1995; 18:217-221.
10. Chen S-C, Lian S-L, Chang W-Y, et al: The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33(Suppl):S124-S127.
11. Minagawa M, Makuuchi M, Takayama T, et al: Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001; 233:379-384.
12. Fukuda S, Okuda K, Imamura M, et al: Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: Report of 19 cases. Surgery 2002; 131:300-310.
13. Bayraktar Y, Balkanci F, Kayhan B, et al: Congenital hepatic fibrosis associated with cavernous transformation of the portal vein. Hepatogastroenterology 1997; 44(18):1558-1594.
14. Okuda K, Musha H, Yamasaki T, et al: Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology 1977; 122:53-58.
15. Okuda K, Musha H, Yoshida T, et al: Demonstration of growing casts of hepatocellular carcinoma in the portal vein by celiac angiography: The thread and streaks sign. Radiology 1975; 117:303-309.
16. Didier M, Phillippe G, Bominipuev L, et al: Portal vein involvement in hepatocellular carcinoma: dynamic CT features. Radiology 1984; 152:127-132.
17. Nishikawa J, Itai Y, Tasaka A, et al: Lobar attenuation difference of the liver on computed tomography. Radiology 1981; 141:725-728.
18. Livraglii T, Makuuchi M, Buscartni L: Diagnosis and Treatment of hepatocellular carcinoma. In: Roche (Ed.). Angiography. London: Greenwich Medical Media, 1997; pp. 129-139.
19. Furuse J, Iwasaki M, Yoshino M, et al: Hepatocellular carcinoma with portal vein tumor thrombus: embolization of arterioportal shunts. Radiology 1997; 204:787-790.
20. Maria A, Lafortune M, Patriquin H, et al: Cavernous transformation of the portal vein; patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography. AJR 1995; 165:1151-1155.
21. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
22. Allison DJ, Jordan H, Hennessy O: Therapeutic embolization of the hepatic artery: a review of 75 procedures. Lancet 1985; 1:595-599.
23. Bismuth H, Morino M, Sherlock D, et al: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163:387-394.
24. Lee HS, Kim JS, Choi IJ, et al: The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997; 79:2087-2094.
25. Konishi M, Ryu M, Kinoshita T, et al: Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in main portal vein. Hepatogastroenterology 2001; 48:1421-1424.
26. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985; 56:918-928.
27. Marks WM, Jacobs RP, Goodman PC, et al: Hepatocellular carcinoma: Clinical and angiographic findings and predictability for surgical resection. AJR 1979; 132:7-11.
28. Ryu M, Shimamura Y, Kinoshita T, et al: Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997; 27(4)251-257.
29. Molmenti EP, Klintmalm GB: Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transplantation 2002; 9:736-748.
30. Marsh JW, Dvorchik I, Bonham CA, et al: Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000; 88:538-543.
31. Pinna AD, Iwatsuki S, Lee RG, et al: Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26:877-883.
32. Yao FY, Ferrell L, Nathan M, et al: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh Modified TNM Criteria. Liver Transplant 2002; 8(9):765-774.
33. Lai CL, Lau JY, Wu PC, et al: Recombinant interferon- alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology 1993; 17:389-394.
34. Sakon M, Nagano H, Bono K: Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94:435-442.
35. Patt YZ, Yoffe B, Charnsangavej C, et al: Low serum alpha-fetoprotein level in patients with hepatocellular carcinoma as a predictor of response to 5-FU and interferon-alpha-2b. Cancer 1993; 72:2574-2582.